NOVONIX Ltd (NVX) Current Deferred Revenue (2020 - 2025)
Novonix (NVX) posted quarterly Current Deferred Revenue of $146475.0 for Q4 2025, up 16.2% year-over-year from $126056.0 in Q4 2024, and up 16.2% quarter-over-quarter from $126056.0 in Q4 2024.
NOVONIX Ltd (NVX) Current Deferred Revenue (2020 - 2025) Analysis & Trends
Novonix's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $146475.0 for Q4 2025.
- In Q4 2025, Current Deferred Revenue rose 16.2% year-over-year to $146475.0; the TTM figure through Dec 2025 stood at $146475.0 (up 16.2% YoY), while the FY2025 annual figure was $146475.0, up 16.2% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $146475.0, up from $126056.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $324131.0 in Q2 2024, with the low at $2820.7 in Q2 2022.
- The 5-year median for Current Deferred Revenue is $246484.8 (2021), against an average of $207861.8.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue slumped 98.82% in 2022, then soared 8911.14% in 2023.
- Novonix's Current Deferred Revenue stood at $238795.6 in 2021, then rose by 19.44% to $285221.0 in 2022, then changed by 0.0% to $285221.0 in 2023, then plunged by 55.8% to $126056.0 in 2024, then rose by 16.2% to $146475.0 in 2025.
- Business Quant data shows NVX's Current Deferred Revenue at $146475.0 in Q4 2025, $126056.0 in Q4 2024, and $324131.0 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,475.00 |
| Dec 31, 2024 | 126,056.00 |
| Jun 30, 2024 | 324,131.00 |
| Dec 31, 2023 | 285,221.00 |
| Jun 30, 2023 | 254,174.00 |
| Dec 31, 2022 | 285,221.00 |
| Jun 30, 2022 | 2,820.66 |
| Jun 30, 2021 | 238,795.64 |
| Jun 30, 2020 | 1.23 Mn |